The BioInsights Podcast
A podcast by BioInsights
55 Episodes
-
Can AAV continue to deliver the promise of gene therapy?
Published: 9/13/2023 -
Expanding the potential of in vivo cell therapy with tLNP-RNAs (targeted lipid nanoparticle-RNA)
Published: 8/30/2023 -
Investing long-term in the cell & gene therapies of the future
Published: 8/22/2023 -
Happy medium: considerations in scaling cell culture media strategies
Published: 8/16/2023 -
Applying multiomics to novel target discovery in immuno-oncology
Published: 8/8/2023 -
Modernizing cell therapy manufacturing to reduce vein-to-vein times
Published: 7/26/2023 -
Inducing innate immune responses with particulate adjuvants
Published: 7/26/2023 -
Navigating the complexities of biodistribution, transgene expression & vector shedding in gene therapy development
Published: 6/9/2023 -
Non-viral methods for ex vivo cell & gene therapy: is the future non-viral?
Published: 5/31/2023 -
Solving challenges in cell therapy clinical trials & effectively delivering complex studies in advanced therapeutics
Published: 4/17/2023 -
Shear ignorance? Think again: breaking the perception of shear within viral vector manufacturing
Published: 4/6/2023 -
Challenges in cryogenic storage containers for cell and gene therapy
Published: 3/22/2023 -
Maximizing Efficiency and Flexibility in Viral Vector Manufacturing Scale-up
Published: 3/2/2023 -
Improvement of viral vector purification using Mustang Q membrane chromatography
Published: 12/13/2022 -
Shear ignorance? Think again: breaking the perception of shear within viral vector manufacturing
Published: 11/9/2022 -
CAR-T cells: from cancer to autoimmunity
Published: 10/12/2022 -
Tales, tips & teachable moments from applications support veterans
Published: 10/11/2022 -
Access to vaccines: how can we leverage technology innovations to achieve greater vaccine equity?
Published: 9/30/2022 -
De-risk & accelerate the drug development process for gene therapy
Published: 9/29/2022 -
Working Together to Safely Advance Cell & Gene Therapies
Published: 9/27/2022
The BioInsights Podcast: discussing the challenges of translating novel biologics from bench to clinic to market.